XM does not provide services to residents of the United States of America.
T
T

Take-Two

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

U.S. Galapagos, Marsh & Mclennan, Travelers

U.S. RESEARCH ROUNDUP-Galapagos, Marsh & Mclennan, Travelers Oct 22 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Galapagos, Marsh & Mclennan and Travelers, on Tuesday. HIGHLIGHTS * Contineum Therapeutics Inc CTNM.O : Baird initiates coverage with outperform rating * Galapagos NV GLPG.O : JP Morgan cuts target price to $32 from $37 * Marsh & Mclennan MMC.N : KBW raises target price to $212 from $209 * Travelers TRV.
A
C
E
E
G
M
T
W
Z
A
F
T
L
P
U
W
P
S

caps poised to have their day?

LIVE MARKETS-SMID-caps poised to have their day? S&P 500, Dow green; Nasdaq slips Utilities lead S&P 500 sectors gainers; Comm Svcs weakest group Euro STOXX 600 off ~0.2% Dollar, gold gain; bitcoin up ~2%; crude edges red U.S. 10-Year Treasury yield dips to ~4.01% Welcome to the home for real-time coverage of markets brought to you by Reuters reporters.
T
U
U
E

Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT

BUZZ - Nasdaq top and bottom performing stocks at about 03:45 p.m. EDT Nasdaq 100 .NDX Top Performers Percent Change Constellation Energy Corp CEG.OQ +3.9% Diamondback Energy Inc FANG.OQ +3.7% NVIDIA Corp NVDA.OQ +3.0% Paccar Inc PCAR.OQ +2.8% Trade Desk Inc TTD.OQ +2.2% Bottom Performers Percent Change Tesla Inc TSLA.OQ -3.9% Warner Bros Discovery Inc WBD.OQ -3.5% Take-Two Interactive Software Inc TTWO.OQ -2.9% Moderna Inc MRNA.OQ -2.8% Regeneron Pharmaceuticals Inc REGN.OQ -2.8% The Nasdaq 100
N
P
R
T
T
U
D
T

IBM sues Take-Two for patent infringement over internet technology

IBM sues Take-Two for patent infringement over internet technology By Blake Brittain Sept 30 - IBM IBM.N sued video-game maker Take-Two Interactive TTWO.O in Delaware federal court on Monday for allegedly violating its patent rights covering a range of internet-related technology. IBM said in its lawsuit that a Take-Two game launcher and entries from its popular NBA 2K, Grand Theft Auto and Red Dead Redemption series infringe IBM patents related to web advertising, virtual worlds and user authen
G
T

Ubisoft activist investor says it has support of 10% of shareholders in management tussle

EXCLUSIVE-Ubisoft activist investor says it has support of 10% of shareholders in management tussle By Zaheer Kachwala Sept 26 (Reuters) - An activist investor pushing for a sale of "Assassin's Creed" maker Ubisoft UBIP.PA has gathered support from 10% of the French videogame publisher's shareholders, it said in a letter on Thursday that was exclusively shared with Reuters.
U
T

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.